Aligos Therapeutics Inc

ALGS

Add to Watchlist

5.650USD

-0.040-0.70%

Close 06/23, 16:00（ET）Quotes delayed by 15 min

34.96MMarket Cap

LossP/E TTM

Aligos Therapeutics Inc

5.650

-0.040-0.70%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-06-23

Previous score

5.00

Change

The current institutional shareholding score of Aligos Therapeutics Inc is 5.00, ranking 133 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 52.29%, representing a quarter-over-quarter decrease of 33.43%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.62% of shares outstanding, with 13.10% decrease in holdings.